SCM
ROIV icon

Superstring Capital Management’s Roivant Sciences ROIV Stock Holding History

Superstring Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-531,019
Closed -$5.6M – 54
2024
Q1 		$5.6M Buy
531,019
+204,858
+63% +$2.21M 3.7% 9
2023
Q4 		$3.66M Buy
+326,161
New +$3.18M 2.61% 14

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Superstring Capital Management's ROIV Position: Q2 2024 in Review

Superstring Capital Management sold out of Roivant Sciences (ROIV) in Q2 2024, closing a stake of 531,019 shares — an estimated $5.6M sold.

Superstring Capital Management first reported a position in ROIV in Q4 2023 and held it in 2 quarters. The position peaked at $5.6M in Q1 2024. 293 funds tracked by Wall St. Rank hold ROIV as of Q2 2024.

  • Superstring Capital Management reported no remaining Roivant Sciences position as of Q2 2024 after selling out during the quarter.
  • Superstring Capital Management sold 531,019 Roivant Sciences shares in Q2 2024, an estimated $5.6M.
  • Superstring Capital Management first reported a position in Roivant Sciences in Q4 2023 and held it in 2 quarters.
  • Superstring Capital Management's Roivant Sciences position peaked at $5.6M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2024.

Based on Superstring Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.